<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

The Cancer Letter

Obama Calls for Bigger Investment in Science, GOP Plans Cuts

January 28, 2011

Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020

January 28, 2011

ASCO Recommends End of Life Discussions

January 28, 2011

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011